IGC
IGC Pharma·AMEX
--
--(--)
--
--(--)
5.73 / 10
Netural
Fund flow is rated good (6.85/10) with a net inflow across all size bands, indicating buying interest despite the negative price trend. Analyst coverage is limited to one institution (Ascendiant Capital) but consistently Strong Buy. This bullish sentiment contrasts with the negative fund-flow trends at the block and large-inflow levels, suggesting that retail or small-cap flows are supporting the stock while larger players remain hesitant. The combination of positive money flow and strong analyst conviction partially offsets the neutral-to-bearish technicals and fundamentals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-09
InstitutionAscendiant Capital
Times predicted3
Historical Win Rate66.7%
What is the market sentiment for IGC?
- IGC holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.73/10 (Netural).
